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1. Introduction 
A diminished capacity of sap from tissues of diabetic 
animals to support incorporation of amino acids into 
protein in cell-free systems has several times been noted 
[l-3] . Conversely there is evidence that long-term 
protein malnutrition enhances the activity of the 
hepatic amino acid activating enzymes [4, 51. There 
are surprisingly no reports of the effect of fasting on 
the capacity of sap to support protein synthesis by 
isolated ribosomes, though after 6 days without food 
the hepatic content of amino acid activating enzymes 
is said to be unchanged [4] _ 
We find that sap from liver and muscle of fasted 
rats has a lower capacity to support protein synthesis 
and that this decrease is not attributable to change 
in the size of the pool of free amino acids. 
2. Methods 
Sap and ribosomes were prepared from liver of 
rats of about 120 g wt that had either free access to 
food or had food withdrawn 48 hr previously. Diabetes 
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was induced by intravenous injection of alloxan (65 
mg/kg) 60 hr previously. 
Livers were homogenised at 4’ with a Dounce homo- 
geniser in 2.5 vol medium containing 50 mM tris-HCl, 
pH 7.6, 100 mM KCl, 5 mM MgCl, 0.25 M sucrose and 
6 mM mercaptoethanol. The homogenate was centri- 
fuged at 10,000 g for 15 min and the supernatant 
treated with a-amylase (Worthington Biochemical 
Corp. - 50 units per ml supernatant [6] ) to degrade 
any glycogen present. The portion of the supernatant 
that was to become the sap was then centrifuged at 
150,OOOg for 1 hr and the supernatant collected, 
care being taken to avoid gathering any lipid at the 
top of the tube. The portion of the 100,000 g super- 
natant that was to be used as a source of ribosomes 
was made 1% with respect to deoxycholate and then 
layered over buffer containing 1 M sucrose and also 
centrifuged for I hr at 150,000 g. The ribosomal 
pellet was suspended in 2 ml of buffer, centrifuged 
lightly and aliquots of supernatant taken for deter- 
mination of RNA [7] . 
The cell sap was either used directly or passed 
through a column of Sephadex G25 equilibrated with 
buffer [8] , during which some dilution took place. 
For preparation of ‘pH 5 fraction’ 1 N acetic acid was 
added slowly with stirring to 6-8 ml of sap until the 
pH fell to 5. The precipitate was collected, washed 
once by suspension in 0.25 M sucrose in water [9], 
then redissolved in buffer equal in volume to l/5 of 
that of supernatant used for precipitation. Protein 
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Table 1 
Effect of various factors on incorporation of leucine into 
protein by liver ribosomes. 
System 
Complete 
No sap 
Ribosome 
suspension 
(ml) 
0.10 
0.05 
0.02 
0.01 
0 
0.10 
Incorporation into protein 
@pm) (%I 
4358 100 
2170 53 
875 19 
440 11 
150 5 
141 4 
No ATP and 
GTP 
0.10 3519 
No PEP 0.10 2842 61 
The complete system is as described in the methods section 
and contained 0.1 ml sap. In the experiment indicated the 
ribosomal suspension contained 2.4 mg RNA/ml. The per- 
centage changes are the average of 5 separate experiments. 
content of sap and pH 5 fraction was measured by 
the method of Lowry et al. [lo] . 
The incubation medium for incorporation of 
leucine into protein contained in addition to the 
other constituents of the homogenising medium: 
1 mM ATP, 0.1 mM GTP, 5 mM phosphoenolpyruvate, 
additional MgClz to 6 mM (free Mg’ + likely to be 
around 3.2 mM [ 1 l] ), as well as various amounts of 
sap and ribosomal suspension, and l-14C-leucine 
added at a concentration of either 15 or 100 PM 
(about 0.4 /.&i per tube), total vol. 0.5 ml. Incuba- 
tion was for 30 min at 37”, after which 2 ml of 10% 
TCA containing 1 mg/ml DL-leucine was added. The 
precipitate was collected and resuspended in 3 ml of 
the TCA/leucine solution, heated for 15 min at 90” 
then collected on glass fibre discs (Whatman) and 
further washed with TCA. The discs were placed in 
10 ml scintillation fluid (toluene-Triton X-100,2: 1, 
containing 0.4% BBOT), which dislodged the protein 
from the discs, and the radioactivity counted at about 
70% efficiency. 
3. Results. 
In initial experiments the incorporating system 
Table 2 
Capacity of ribosomes and sap from fed and fasted rats to 
incorporate leucine into protein. 
Sap from liver Ribosomes prepared from animals fasted 
of rats fasted (days) 
(days) 
0 1 2 
0 686 655 524 
1 577 506 460 
2 559 513 472 
Sap from muscle 
of rats fasted 
(days) 
0 597 553 521 
1 374 365 310 
2 433 372 357 
Incorporation is expressed as pmole leucine incorporated per 
mg ribosomal RNA. 0.1 ml of sap was added to each tube. 
contained 0.1 ml of sap (equivalent to about 30 mg 
of liver). The amount of leucine incorporated was 
proportional to the quantity of ribosomes added in 
the range up to about 250 pg per tube of ribosomal 
RNA (table 1). Incorporation was substantially less 
when phosphoenolpyruvate was omitted, but was not 
seriously affected by omission of ATP and GTP, pre- 
sumably because the sap contained appreciable nu- 
cleotide only in need of a regenerating system. No 
pyruvate kinase was added since the sap contains 
adequate endogenous activity (unpublished observa- 
tions). Omission of ribosomes or of a sap reduced in- 
corporation to near zero levels. 
Table 2 shows the results of an experiment in 
which the activity of sap prepared from both liver 
and muscle of animals fasted for various periods is 
studied in.conjunction with hepatic ribosomes, the 
ribosomes also being used in the similar conditions. 
There is consistent diminution in the activity of sap 
from both tissues from fasting animals to support in- 
corporation as well as decrease in the activity of the 
ribosomes. The diminished activity of ribosomes from 
liver of fasted rats has been previously observed [ 12, 
131, but the change in activity of the sap appears not 
to have been noted and merited further attention. The 
difference if even greater when the figures are correc- 
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Fig. 1. Effect of various amounts of sap from liver of fed and 
fasted rats on the incorporation of leucine into protein by he- 
patic ribosomes. o---o sap from fed rats; cc--i;, fasted for 48 
hr. In (a) incorporation is not corrected for the different 
amounts of protein in the two saps; in (b) the results of (a) are 
divided by the quantity of protein (mg) in 0.1 ml of the appro- 
priate sap. 
ted to comparable amounts of protein as in the expe- 
riment in fig. 1. In fact sap from fasted animals nor- 
mally contained more protein than that from fed sour- 
ces, presumably because of the lower glycogen in the 
tissue. Variation in the amount of sap added did not 
make a large difference in the amount of incorpora- 
tion (fig. 1). Saturation of the system with respect to 
sap could be a correct interpretation of these findings 
(though less than the critical 25: 1 ratio of sap:riboso- 
ma1 protein noted by Munro et al. [8] was used), but 
similar results could arise if leucine added with the sap 
diluted the specific activity of the labelled leucine. 
30 mg of tissue contains roughly 8 nmoles of free 
leucine, which is about the same amount as that added 
in labelled form. Diminution in incorporation with 
the fasted sap could arise if the dilution were greater 
(though there is little evidence for enhanced leucine 
levels in fasting liver [ 14-161). In order to clarify 
the point the experiments were repeated using sap 
which had been passed through Sephadex to remove 
low molecular weight contaminants and by increasing 
the amount of added leucine to the point where dilu- 
tion was not likely to pose a serious problem. 
Sap added I p’l 
Fig. 2. Effect of sap after Sephadex filtration on its ability 
to support incorporation of leucine by hepatic ribosomes. 
Details as in fig, 1 
Fig. 2a shows that after passage of the sap through 
Sephadex incorporation is proportional to the amount 
of sap added and that the difference between the sap 
from fed and fasted rats persists. (Again, the difference 
is greater then the values are corrected to comparable 
amounts of protein (fig. 2b). Moreover similar diffe- 
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3. Effects of sap from fed, fasted and diabetic liver, both Fig. 
before (open symbols) and after (closed symbols) Sephadex 
filtration, to support incorporation by hepatic ribosomes of 
leucine added at saturating concentration (0.1 mM). D--O, 
sap from fed; W- -0, fasted; n--n, diabetic liver. Note that 
incorporation is corrected for different amounts of protein 
in the sap. 
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Fig. 4. Effects of ‘pH 5 enzyme’ fraction, prepared from sap 
of fed, fasted and diabetic liver to support incorporation by 
hepatic ribosomes. o-o sap from fed; o -a, fasted and b A, 
diabetic livers. The amount of incorporation has been divided 
by the quantity of protein (mg) in 0.1 ml of the appropriate 
pH 5 fraction. F’yruvate kinase (Boehringer 50 rg) was added 
to each tube. 
rences were found when the concentration of leucine 
was raised (fig. 3). Under these conditions the diffe- 
rence between the capacity of untreated sap and sap 
passed through Sephadex declines, which suggests 
that Sephadex treatment primarily diminishes dilution 
of the specific activity of the added amino acid as 
opposed to removing putative inhibitors present in 
the sap [8] , This last experiment included sap from 
severely ketotic alloxan diabetic rats which possessed 
a lower activity by comparison with the fed normal 
and also with the fasted sap. 
The differences between sap from fed and fasted 
rats persists when the pH fraction of the sap is used 
in place of whole sap (fig. 4). It should be noted here 
that the diminished capacity is seen only when ex- 
pressed in terms of unit quantity of pH 5 fraction; 
fasted sap usually produced a larger quantity of pro- 
tein which in total exhibited greater support for in- 
corporation. There was also less specific activity in 
the precipitate from diabetic sap compared with fed 
sap- 
4. Discussion 
The present results confirm earlier findings [8] 
that the in vitro system is not saturated with sap at 
ratios of sap to ribosome protein of around 10: 1 such 
as have been used here, though this may not be ap- 
parent unless sap is treated with Sephadex. That the 
system should not be saturated is presumably neces- 
sary in order for a difference in functional capacity 
to be detectable and the use of differing ratios of sap 
or pH 5 proteins to ribosomes may explain some of 
the variability in extent of change of function in dia- 
betes [ 1-3, 17, 181. That functional capacity of sap 
should decline in diabetes suggests that the fall in 
starvation may relate to lower circulating insulin le- 
vels and indeed injection of insulin to normal animals 
raises the activity of the sap [ 191 . Conversely there 
may be mechanisms other than endocrine which in- 
fluence rates of protein synthesis in both liver and 
muscle according to dietary state [20]. In the in 
vitro system used here the ribosomes are enriched 
with respect to the intracellular ratio of sap to ribo- 
somes, which might influence how important such 
changes will be in vivo. Sap or.pH 5 fraction is of 
course a mixture of components. If indeed fasting does 
not reduce the activity of amino acid activating en- 
zymes [4], the change may lie in some aspect of the 
amino acid accepting capacity of the transfer-RNA 
[21] which could be related to changes in the iso- 
accepting forms as noted after hypophysectomy [22]. 
On the grounds that there is little initiation taking 
place in hepatic cell-free systems [23] it is unlikely 
that changing availability of initiation factors is 
chiefly responsible. With sap from diabetic muscle 
the defect appears to lie in aminoacyl-tRNA charging 
rather than the content of transferase [3] . In bacteria 
the sap fraction also appears to exercise a controlling 
influence, the presence of an inhibitor being implica- 
ted [24]. Further work is required to determine whe- 
ther factors in mammalian sap claimed both to en- 
hance and inhibit ribosome activity [25, 261 are res- 
ponsible for the present observations. 
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